UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a

Deuis, JR; Dekan, Z; Wingerd, JS; Smith, JJ; Munasinghe, NR; Bhola, RF; Imlach, WL; ... Vetter, I; + view all (2017) Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a. Scientific Reports , 7 , Article 40883. 10.1038/srep40883. Green open access

[img] Text (Published article)
Deuis_Pharmacological characterisation of the highly NaV17 selective spider venom.pdf - ["content_typename_Published version" not defined]

Download (2MB)
[img]
Preview
Text (Supplementary information)
Deuis_Pharmacological characterisation of the highly NaV17 selective spider venom SUPPL.pdf

Download (359kB) | Preview

Abstract

Human genetic studies have implicated the voltage-gated sodium channel NaV1.7 as a therapeutic target for the treatment of pain. A novel peptide, μ-theraphotoxin-Pn3a, isolated from venom of the tarantula Pamphobeteus nigricolor, potently inhibits NaV1.7 (IC50 0.9 nM) with at least 40-1000-fold selectivity over all other NaV subtypes. Despite on-target activity in small-diameter dorsal root ganglia, spinal slices, and in a mouse model of pain induced by NaV1.7 activation, Pn3a alone displayed no analgesic activity in formalin-, carrageenan- or FCA-induced pain in rodents when administered systemically. A broad lack of analgesic activity was also found for the selective NaV1.7 inhibitors PF-04856264 and phlotoxin 1. However, when administered with subtherapeutic doses of opioids or the enkephalinase inhibitor thiorphan, these subtype-selective NaV1.7 inhibitors produced profound analgesia. Our results suggest that in these inflammatory models, acute administration of peripherally restricted NaV1.7 inhibitors can only produce analgesia when administered in combination with an opioid.

Type: Article
Title: Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/srep40883
Publisher version: http://dx.doi.org/10.1038/srep40883
Language: English
Additional information: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Wolfson Inst for Biomedical Research
URI: http://discovery.ucl.ac.uk/id/eprint/1538505
Downloads since deposit
112Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item